A method using gas chromatography high-resolution mass spectrometry was developed to detect and measure the designer hallucinogen 5-MeO-DIPT in urine. Two metabolites, 5-OH-DIPT and 5-MeO-IPT, were identified in users' urine. The method accurately quantified 5-MeO-DIPT between 2 and 300 ng/mL, with a detection limit of 1 ng/mL. In drug abusers, urine concentrations ranged from 1 to 2.8 ng/mL. Stability testing showed that 5-MeO-DIPT concentration decreased by 22.8% after 24 hours at 25°C, 33.2% after 5 days at 4°C, and 38.2% after 7 days at 4°C, but was stable for 30 days at -20°C. Freezing urine samples is recommended for accurate analysis.
A dried urine spot (DUS) method using LC-MS/MS was developed to measure the tryptamine hallucinogen 5-MeO-DIPT, which is unstable in liquid urine. Ten microliters of urine were spotted on a card and extracted with methanol. The method's limit of detection was 0.1 ng/ml and lower limit of quantification was 0.2 ng/ml, with accuracy between 98.2% and 103.9% and precision between 2.7% and 8.5%. 5-MeO-DIPT was more stable in DUS than in urine stored at 25 °C. When applied to urine from known users, concentrations ranged from 0.3 to 2.3 ng/ml, lower than those measured by GC-Orbitrap-MS. The small sample volume and simplicity make this useful for drug screening.